FDA Generic Drug Reviews Routinely Delayed: Study
The U.S. Food and Drug Administration was unable to review nearly half of all generic drug applications on time because of a problematic review system and insufficient funds and staff, according...To view the full article, register now.
Already a subscriber? Click here to view full article